DOJ Delay Raises New Research Questions | TDR Cannabis in 5

The Dales Report | Trade to Black · Jan 25, 2026 · 7m

What’s actually happening with cannabis research at the federal level — and why does it matter right now?In this episode of TDR Cannabis in Five, the focus turns to a quieter but critical development tied directly to federal cannabis reform. While much of the attention has been on marijuana rescheduling, a key deadline tied to cannabis research quietly passed without action. The U.S. Attorney General missed a congressionally mandated date to issue new rules that would clarify how researchers study Schedule I substances, including cannabis and psychedelics.That delay matters. For decades…